[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.7314/APJCP.2012.13.5.1823

siRNA Mediated Silencing of NIN1/RPN12 Binding Protein 1 Homolog Inhibits Proliferation and Growth of Breast Cancer Cells

Huang, Wei-Yi (Department of Oncology, Affiliated People's 1st Hospital, Shanghai Jiaotong University)
Chen, Dong-Hui (Department of Oncology, Affiliated People's 1st Hospital, Shanghai Jiaotong University)
Ning, Li (Department of Oncology, Affiliated People's 1st Hospital, Shanghai Jiaotong University)
Wang, Li-Wei (Department of Oncology, Affiliated People's 1st Hospital, Shanghai Jiaotong University)

Publication Information

Asian Pacific Journal of Cancer Prevention / v.13, no.5, 2012 , pp. 1823-1827 More about this Journal

Abstract

The gene encoding the Nin one binding (NOB1) protein which plays an essential role in protein degradation has been investigated for possible tumor promoting functions. The present study was focused on NOB1 as a possible therapeutic target for breast cancer treatment. Lentivirus mediated NOB1 siRNA transfection was used to silence the NOB1 gene in two established breast cancer cell lines, MCF-7 and MDA-MB-231, successful transfection being confirmed by fluorescence imaging. NOB1 deletion caused significant decline in cell proliferation was observed in both cell lines as investigated by MTT assay. Furthermore the number and size of the colonies formed were also significantly reduced in the absence of NOB1. Moreover NOB1 gene knockdown arrested the cell cycle and inhibited cell cycle related protein expression. Collectively these results indicate that NOB1 plays an essential role in breast cancer cell proliferation and its gene expression could be a therapeutic target.

Keywords

Breast cancer; NOB1; proliferation; colony formation; siRNA;

Citations & Related Records

Reference

1	Adams J (2004). The proteasome: a suitable antineoplastic target. Nat Rev Cancer, 4, 349-60. DOI
2	Fasanaro P, Capogrossi MC, Martelli F (2010). Regulation of the endothelial cell cycle by the ubiquitin-proteasome system. Cardiovasc Res, 85, 272-80. DOI
3	Ferrell K, Wilkinson CR, Dubiel W, Gordon C (2000). Regulatory subunit interactions of the 26S proteasome, a complex problem. Trends Biochem Sci, 25, 83-8. DOI
4	Hanahan Da WRA (2000). The hallmarks of cancer. Cell, 100, 57-70. DOI ScienceOn
5	Hershko Aa CA (1998). The ubiquitin system. Annual Review Biochem, 67, 425-79. DOI ScienceOn
6	Lin Y, Peng S, Yu H, Teng H, Cui M (2012). RNAi-mediated downregulation of NOB1 suppresses the growth and colonyformation ability of human ovarian cancer cells. Med Oncol, 29, 311-7. DOI
7	Lu Z, Guo Q, Shi A, Xie F, Lu Q (2012). Down regulation of NIN/RPN12 binding protein inhibit the growth of human hepatocellular carcinoma cells. Mol Biol Rep, 39, 501-7. DOI
8	Mello CC, Conte D Jr. (2004). Revealing the world of RNA interference. Nature, 431, 338-42. DOI
9	Pertschy B, Schneider C, Gnadig M, et al (2009). RNA helicase prp43 and its co-factor Pfa1 promote 20 to 18S rRNA processing catalyzed by the endonuclease Nob1. J Biol Chem, 284, 35079-91. DOI
10	Shirane M, Harumiya Y, Ishida N, et al (1999). Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J Biol Chem, 274, 13886-93. DOI
11	Soneoka Y, Cannon PM, Ramsdale E, et al (1995). A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res, 23, 628-33. DOI
12	Storvold GL, Andersen TI, Perou CM, Frengen E (2006). siRNA: a potential tool for future breast cancer therapy? Crit Rev Oncog, 12, 127-50. DOI
13	Tone Y, Toh-E A (2002). Nob1p is required for biogenesis of the 26S proteasome and degraded upon its maturation in Saccharomyces cerevisiae. Genes Dev, 16, 142-57.
14	Zhang Y, Ni J, Zhou J, et al (2005). Cloning, expression and characterization of the human NOB1 gene. Mol Biol Rep, 32, 185-9. DOI
15	Xu G, Bernaudo S, Fu G, et al (2008). Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7. Mol Biol Cell, 19, 4968-79. DOI

Reference

3	(2013) Journal of International Medical Research gene and its clinical significance in papillary thyroid carcinoma / 41 (3) , 568
4	Jie Chen. (2015) Molecular Medicine Reports Positive nin one binding protein expression predicts poor outcome in prostate cancer / 11 (4) , 2671
2	Kun Liu. (2014) Pathology & Oncology Research NOB1 in Non-small-cell Lung Cancer: Expression Profile and Clinical Significance / 20 (2) , 461
3	(2014) Oncology Reports Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo / 31 (3) , 1271
6	(2014) Oncology Reports Adenovirus-mediated siRNA targeting NOB1 inhibits tumor growth and enhances radiosensitivity of human papillary thyroid carcinoma in vitro and in vivo / 32 (6) , 2411
1-2	Xiangmin Zhang. (2014) Molecular and Cellular Biochemistry Knockdown of NOB1 expression inhibits the malignant transformation of human prostate cancer cells / 396 (1-2) , 1
5	(2014) Molecular Medicine Reports ADAM17 silencing suppresses the migration and invasion of non-small cell lung cancer / 9 (5) , 1935
5	Lei Wu. (2015) Oncology Reports MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein / 33 (5) , 2309
3	Weiyi Huang. (2015) Oncology Reports Lentivirus-mediated gene silencing of NOB1 suppresses non-small cell lung cancer cell proliferation / 34 (3) , 1510
6	Jirong Yin. (2015) Oncology Reports Downregulation of NOB1 inhibits proliferation and promotes apoptosis in human oral squamous cell carcinoma / 34 (6) , 3077
1791-2431	Jia Liu. (2015) Oncology Reports Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo / (1791-2431)
6	(2016) Oncology Reports NOB1 silencing inhibits the growth and metastasis of laryngeal cancer cells through the regulation of JNK signaling pathway / 35 (6) , 3313
2	(2016) International Journal of Molecular Medicine miR-192 suppresses the tumorigenicity of prostate cancer cells by targeting and inhibiting nin one binding protein / 37 (2) , 485